The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The enzyme arginase 1 (A1) hydrolyzes the amino acid arginine to form L-ornithine and urea. Ornithine is further converted to polyamines by the ornithine decarboxylase (ODC) enzyme. We previously reported that deletion of myeloid A1 in mice exacerbates retinal damage after ischemia/reperfusion (IR) injury. Furthermore, treatment with A1 protects against retinal IR injury in wild-type mice. PEG-A1 also mitigates the exaggerated inflammatory response of A1 knockout (KO) macrophages in vitro. Here, we sought to identify the anti-inflammatory pathway that confers macrophage A1-mediated protection against retinal IR injury. Acute elevation of intraocular pressure was used to induce retinal IR injury in mice. A multiplex cytokine assay revealed a marked increase in the inflammatory cytokines interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) in the retina at day 5 after IR injury. In vitro, blocking the A1/ODC pathway augmented IL-1β and TNF-α production in stimulated macrophages. Furthermore, A1 treatment attenuated the stimulated macrophage metabolic switch to a pro-inflammatory glycolytic phenotype, whereas A1 deletion had the opposite effect. Screening for histone deacetylases (HDACs) which play a role in macrophage inflammatory response showed that A1 deletion or ODC inhibition increased the expression of HDAC3. We further showed the involvement of HDAC3 in the upregulation of TNF-α but not IL-1β in stimulated macrophages deficient in the A1/ODC pathway. Investigating HDAC3 KO macrophages showed a reduced inflammatory response and a less glycolytic phenotype upon stimulation. In vivo, HDAC3 co-localized with microglia/macrophages at day 2 after IR in WT retinas and was further increased in A1-deficient retinas. Collectively, our data provide initial evidence that A1 exerts its anti-inflammatory effect in macrophages via ODC-mediated suppression of HDAC3 and IL-1β. Collectively we propose that interventions that augment the A1/ODC pathway and inhibit HDAC3 may confer therapeutic benefits for the treatment of retinal ischemic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“HDAC3 was observed to colocalize with microglia/macrophages during the acute phase of retinal ischemic injury, further supporting the pivotal role of HDAC3 in ischemic contexts (19).”
From Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Treating LPS-induced macrophages with pegylated arginase 1 (PEG-A1) negatively regulated the expression of HDAC3, highlighting a potential bidirectional regulatory interaction between Arg1 and HDAC3.”
From Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, treatment with Arg1 collaborated with ornithine decarboxylase enzyme was found to protect against retinal ischemic injury (19).”
From Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke (2024) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063 · cited 1×
“In contrast to macrophage classical activation that defends against pathogens, macrophage alternative activation is widely documented to play a reparative role in CNS diseases [7], and the A1 enzyme is a hallmark of alternatively activated macrophages (M2) [8].”
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
Palsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397
NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Dorrington, M. G., & Fraser, I. D. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00705 · Cited by 717
PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
Xie, M., Yu, Y., Kang, R., Zhu, S., Yang, L., Zeng, L., Sun, X., Yang, M., Billiar, T. R., Wang, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13280 · Cited by 568
Arginase: A Multifaceted Enzyme Important in Health and Disease
Caldwell, R. W., Rodriguez, P. C., Toque, H. A., Narayanan, S. P., & Caldwell, R. B. (2018) · Physiological Reviews · doi:10.1152/physrev.00037.2016 · Cited by 495 · cited 2×
“A1 converts arginine to L-ornithine, which subsequently is converted to polyamines by the ornithine decarboxylase (ODC) enzyme [9].”
Self-citationChen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J., Mietton, F., Matteoli, G., Hiebert, S., & Natoli, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121131109 · Cited by 397
Bhaskara, S., Chyla, B. J., Amann, J. M., Knutson, S. K., Cortez, D., Sun, Z.-W., & Hiebert, S. W. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.030 · Cited by 372 · cited 1×
“Myeloid-speci fi c HDAC3 KO mice: C57BL/6J fl oxed mice with LoxP sites on either side of exons 7 of HDAC3 ( HDAC3 f/f , originally developed by Dr. Scott W. Hiebert [22]) were kindly provided by Dr. McGee-Lawrence (Augusta University) and bred in our colony.”
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
Mullican, S. E., Gaddis, C. A., Alenghat, T., Nair, M. G., Giacomin, P. R., Everett, L. J., Feng, D., Steger, D. J., Schug, J., Artis, D., et al. (2011) · Genes & Development · doi:10.1101/gad.175950.111 · Cited by 314
Cited by
Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke
Zhang, Y., Li, J., Zhao, Y., Huang, Y., Shi, Z., Wang, H., Cao, H., Wang, C., Wang, Y., Chen, D., et al. (2024) · Science Advances · doi:10.1126/sciadv.ade6900 · Cited by 55
Évora, A., Garcia, G., Rubi, A., Vitis, E. D., Matos, A. T., Vaz, A. R., Gervaso, F., Gigli, G., Polini, A., & Brites, D. M. T. O. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1474012 · Cited by 35
Gericke, A., & Buonfiglio, F. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2905190 · Cited by 32
Lisek, M., Bochenska, N., Tomczak, J., Duraj, J., & Boczek, T. (2025) · Antioxidants · doi:10.3390/antiox14081015 · Cited by 23
“Recent studies have reported that myeloid cells upregulate HDAC3 in a mouse model of RIR injury [59].”
Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury
Shahror, R. A., Shosha, E., Morris, C., Wild, M., Mu, S., Csányi, G., Boerma, M., Rusch, N. J., & Fouda, A. Y. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03159-8 · Cited by 22
“We recently reported that HDAC3 is upregulated in murine retinal microglia/MΦ following IR injury [5].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Shosha, E., Shahror, R. A., Morris, C. A., Xu, Z., Lucas, R., McGee-Lawrence, M. E., Rusch, N. J., Caldwell, R. B., & Fouda, A. Y.
- Affiliations
- Cairo University (EG)
- University of Arkansas for Medical Sciences (US)
- Augusta University (US)
- Corresponding author
- Fouda, Abdelrahman Y.
- ORCID
- Venue
- Cell Death & Disease
- Published
- 2023-09-21
- Volume
- 14
- Issue
- 9
- Pages
- 621-621
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC10514323
- OpenAlex
- W4386935587
- Cited by
- 29
- References
- 40
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 5
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health & Human Services | NIH | National Eye Institute (4 R00 EY029373-03)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- arginase-1, ornithine decarboxylase, HDAC3, retinal ischemia-reperfusion injury, macrophage inflammation, IL-1β, TNF-α, glycolytic metabolism, microglia, anti-inflammatory pathways, polyamine biosynthesis, intraocular pressure
- MeSH terms
- Histone Deacetylase 3, Animals, Arginase, Ischemia, Ornithine, Ornithine Decarboxylase, Retinal Diseases, Tumor Necrosis Factor-alpha, Reperfusion Injury, Cytokines, Myeloid Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury. https://app.cochat.ai/papers/10.1038/s41419-023-06147-7
- The paper
- Shosha, E., Shahror, R. A., Morris, C. A., Xu, Z., Lucas, R., McGee-Lawrence, M. E., Rusch, N. J., Caldwell, R. B., & Fouda, A. Y. (2023). The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury. Cell Death & Disease. https://doi.org/10.1038/s41419-023-06147-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.